Management of side-effects.

Authors:
Address: Department of Hepato-gastroenterology, Centre Hospitalier Intercommunal de Créteil, France. isabelle.rosa@chicreteil.fr
Journal:


Publication:

abstract

The current treatment of chronic hepatitis C is the triple combination of pegylated interferon, ribavirin and a new direct-acting antiviral [either telaprevir (TVR) or boceprevir (BOC)]. This new association produces better viral response rates, but may induce or enhance adverse events, which can lead to discontinuation of treatment. TVR regimens are associated with an increased risk of dermatological side-effects such as rash, albeit generally mild. In these cases, optimal skincare treatments, including emollient creams and topical corticosteroids, allow the continuation of antiviral treatment. In a minority of cases, the rash may be severe and life-threatening, leading to immediate discontinuation of all treatments. The goal for the physician is to differentiate severe cutaneous adverse reactions (SCARs), including DRESS (drug reactions with eosinophilia and systemic symptoms). Anaemia is also more frequent with triple combinations using TVR or BOC. The Management of anaemia requires the use of erythropoietin alpha (EPO) and the need to decrease ribavirin doses. Thus, monitoring haemoglobin has to be more frequent in difficult-to-treat patients such as cirrhosis cases; nevertheless, despite the use of EPO and ribavirin-dose adaptation, blood transfusion is sometimes still required. Thus, triple combination therapy with a DAA is effective, but it increases the rate of adverse events, and adds to the well-known adverse effects of pegylated interferon and ribavirin. This suggests the need for a different clinical and biological management of patients treated with the triple combination.

Copyright © 2011 Elsevier Masson SAS. All rights reserved.



Related Articles
Review Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
Liver Int. 2012
Review Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
Hézode C. Liver Int. 2012 Feb; 32 Suppl 1:32-8.
Review [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Orv Hetil. 2011
Review [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Hunyady B, Kovács B, Battyáni Z. Orv Hetil. 2011 Dec 11; 152(50):1997-2009.
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
J Hepatol. 2012
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
Cacoub P, Bourlière M, Lübbe J, Dupin N, Buggisch P, Dusheiko G, Hézode C, Picard O, Pujol R, Segaert S, et al. J Hepatol. 2012 Feb; 56(2):455-63. Epub 2011 Aug 30.
Review Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Health Technol Assess. 2004
Review Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. Health Technol Assess. 2004 Oct; 8(39):iii-iv, 1-125.
Drug rash with eosinophilia and systemic symptoms due to telaprevir.
Dermatology. 2010
Drug rash with eosinophilia and systemic symptoms due to telaprevir.
Montaudié H, Passeron T, Cardot-Leccia N, Sebbag N, Lacour JP. Dermatology. 2010; 221(4):303-5. Epub 2010 Aug 25.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.